MedTrace Logo

Physical Function in Critical Care (PaciFIC)

NCT02911896 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 151

Last updated 2017-10-30

No results posted yet for this study

Summary

Impairment in physical function is a significant problem for survivors of critical illness. There is a growing urgency to develop a core set of outcome measures, which can be adopted in clinical and research practice to evaluate efficacy in response to interventions such as rehabilitation.

Phase 1: Development of a new outcome measure. This study aims to examine the development of a single outcome measure which may be able to be utilised across the continuum of recovery of critical illness in the evaluation of physical function. The study will involve examination of two common physical function measures - the Physical Function in intensive care test scored (PFIT-s) and De Morton Mobility Index (DEMMI) and the development of a new measure based on rasch principles which may be able to capture physical functioning changes in individuals with critical illness. Aims: (1) To determine the clinical utility of two physical function measures (DEMMI and PFIT-s) when used in isolation across the hospital admission; and (2) To transform the (15-item) DEMMI and (4-item) PFIT-s into a single measure to evaluate function in intensive care survivors using Rasch analytical principles.

Phase 2: Measurement properties of the PACIFIC physical function outcome measure in an independent validation sample.

Conditions

  • Intensive Care (ICU) Myopathy

Sponsors & Collaborators

  • Melbourne Health

    collaborator OTHER

  • Flinders Medical Centre

    collaborator OTHER_GOV

  • National University Hospital, Singapore

    collaborator OTHER

  • Escola Superior da Saude, Brazil

    collaborator UNKNOWN

  • University of Melbourne

    lead OTHER

Principal Investigators

  • Dr Selina M Parry, PhD · University of Melbourne

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-12-31
Completion
2017-08-31

Countries

  • Australia
  • Brazil
  • Singapore

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02911896 on ClinicalTrials.gov